The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion

Albert Juang Ming Yee, Hyun W. Bae, Darin Friess, Sandie M. Roth, Cari Whyne, Mark Robbin, Brian Johnstone, Jung Yoo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background context: There has been recent enthusiasm regarding the potential positive effects of statins on bone. Statins vary in their ability to influence bone activity. Simvastatin has been shown in experimental models to stimulate bone acting growth factors and enhance bone formation. Purpose: The potential efficacy of Simvastatin in enhancing spinal fusion was evaluated in a rabbit posterolateral intertransverse process fusion model. Study design/setting: Posterior lumbar intertransverse process spinal fusion performed on New Zealand White rabbits. Patient/study sample: 44 New Zealand White rabbits. Outcome measures: Spinal fusion as determined by manual palpation testing and fine detail radiography. Bone fusion mass volume and density as determined by CT scan imaging. Methods: Forty-four New Zealand White rabbits underwent posterolateral intertransverse process spine fusion using autogenous iliac crest bone graft. Simvastatin was administered orally in 20 animals and the serum lipid profile quantified in test and control animals. The animals were euthanized 9 weeks following index surgery and the lumbar spine was harvested. Spinal fusion was determined by manual palpation testing and fine detail radiography. The volume and density of the bone fusion mass was quantified by computed tomography. Results: Drug treatment for 9 weeks caused a reduction in serum lipid biochemical markers when compared with controls. The spinal fusion rate, as judged by manual palpation testing (13.0% control group, 16.6% Simvastatin group) and fine detail radiography, was not significantly different comparing treatment with control animals. Accordant with the assessment of spinal fusion, there was no statistically significant effect on the volume of the fusion mass (1224.7±98.7 mm3 in the control group and 1075.9±66.3 mm3 in the Simvastatin group), the density of bone in the lumbar spine or that in the formed fusion mass. Conclusions: Systemic use of Simvastatin caused a reduction in lipid biochemical parameters in treated animals. Successful spinal fusion as judged by manual palpation testing and fine detail radiography was not significantly different in treated versus untreated animals. The bone volume density of the formed fusion mass was not significantly different in treated versus untreated animals. There did not appear to be a significant advantage or disadvantage to the use of Simvastatin rabbit posterolateral spinal fusion. The potential positive effects of statins on bone require further study.

Original languageEnglish (US)
Pages (from-to)391-396
Number of pages6
JournalSpine Journal
Volume6
Issue number4
DOIs
StatePublished - Jul 2006

Fingerprint

Spinal Fusion
Simvastatin
Spine
Rabbits
Palpation
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Radiography
Bone and Bones
Bone Density
Lipids
Control Groups
Bone Development
Serum
Osteogenesis
Intercellular Signaling Peptides and Proteins
Theoretical Models
Biomarkers
Tomography
Outcome Assessment (Health Care)
Transplants

Keywords

  • Bone healing
  • Spine
  • Spine fusion

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion. / Yee, Albert Juang Ming; Bae, Hyun W.; Friess, Darin; Roth, Sandie M.; Whyne, Cari; Robbin, Mark; Johnstone, Brian; Yoo, Jung.

In: Spine Journal, Vol. 6, No. 4, 07.2006, p. 391-396.

Research output: Contribution to journalArticle

Yee, Albert Juang Ming ; Bae, Hyun W. ; Friess, Darin ; Roth, Sandie M. ; Whyne, Cari ; Robbin, Mark ; Johnstone, Brian ; Yoo, Jung. / The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion. In: Spine Journal. 2006 ; Vol. 6, No. 4. pp. 391-396.
@article{2712c0a72637486a8258bf13ec98a3f5,
title = "The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion",
abstract = "Background context: There has been recent enthusiasm regarding the potential positive effects of statins on bone. Statins vary in their ability to influence bone activity. Simvastatin has been shown in experimental models to stimulate bone acting growth factors and enhance bone formation. Purpose: The potential efficacy of Simvastatin in enhancing spinal fusion was evaluated in a rabbit posterolateral intertransverse process fusion model. Study design/setting: Posterior lumbar intertransverse process spinal fusion performed on New Zealand White rabbits. Patient/study sample: 44 New Zealand White rabbits. Outcome measures: Spinal fusion as determined by manual palpation testing and fine detail radiography. Bone fusion mass volume and density as determined by CT scan imaging. Methods: Forty-four New Zealand White rabbits underwent posterolateral intertransverse process spine fusion using autogenous iliac crest bone graft. Simvastatin was administered orally in 20 animals and the serum lipid profile quantified in test and control animals. The animals were euthanized 9 weeks following index surgery and the lumbar spine was harvested. Spinal fusion was determined by manual palpation testing and fine detail radiography. The volume and density of the bone fusion mass was quantified by computed tomography. Results: Drug treatment for 9 weeks caused a reduction in serum lipid biochemical markers when compared with controls. The spinal fusion rate, as judged by manual palpation testing (13.0{\%} control group, 16.6{\%} Simvastatin group) and fine detail radiography, was not significantly different comparing treatment with control animals. Accordant with the assessment of spinal fusion, there was no statistically significant effect on the volume of the fusion mass (1224.7±98.7 mm3 in the control group and 1075.9±66.3 mm3 in the Simvastatin group), the density of bone in the lumbar spine or that in the formed fusion mass. Conclusions: Systemic use of Simvastatin caused a reduction in lipid biochemical parameters in treated animals. Successful spinal fusion as judged by manual palpation testing and fine detail radiography was not significantly different in treated versus untreated animals. The bone volume density of the formed fusion mass was not significantly different in treated versus untreated animals. There did not appear to be a significant advantage or disadvantage to the use of Simvastatin rabbit posterolateral spinal fusion. The potential positive effects of statins on bone require further study.",
keywords = "Bone healing, Spine, Spine fusion",
author = "Yee, {Albert Juang Ming} and Bae, {Hyun W.} and Darin Friess and Roth, {Sandie M.} and Cari Whyne and Mark Robbin and Brian Johnstone and Jung Yoo",
year = "2006",
month = "7",
doi = "10.1016/j.spinee.2005.10.017",
language = "English (US)",
volume = "6",
pages = "391--396",
journal = "Spine Journal",
issn = "1529-9430",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion

AU - Yee, Albert Juang Ming

AU - Bae, Hyun W.

AU - Friess, Darin

AU - Roth, Sandie M.

AU - Whyne, Cari

AU - Robbin, Mark

AU - Johnstone, Brian

AU - Yoo, Jung

PY - 2006/7

Y1 - 2006/7

N2 - Background context: There has been recent enthusiasm regarding the potential positive effects of statins on bone. Statins vary in their ability to influence bone activity. Simvastatin has been shown in experimental models to stimulate bone acting growth factors and enhance bone formation. Purpose: The potential efficacy of Simvastatin in enhancing spinal fusion was evaluated in a rabbit posterolateral intertransverse process fusion model. Study design/setting: Posterior lumbar intertransverse process spinal fusion performed on New Zealand White rabbits. Patient/study sample: 44 New Zealand White rabbits. Outcome measures: Spinal fusion as determined by manual palpation testing and fine detail radiography. Bone fusion mass volume and density as determined by CT scan imaging. Methods: Forty-four New Zealand White rabbits underwent posterolateral intertransverse process spine fusion using autogenous iliac crest bone graft. Simvastatin was administered orally in 20 animals and the serum lipid profile quantified in test and control animals. The animals were euthanized 9 weeks following index surgery and the lumbar spine was harvested. Spinal fusion was determined by manual palpation testing and fine detail radiography. The volume and density of the bone fusion mass was quantified by computed tomography. Results: Drug treatment for 9 weeks caused a reduction in serum lipid biochemical markers when compared with controls. The spinal fusion rate, as judged by manual palpation testing (13.0% control group, 16.6% Simvastatin group) and fine detail radiography, was not significantly different comparing treatment with control animals. Accordant with the assessment of spinal fusion, there was no statistically significant effect on the volume of the fusion mass (1224.7±98.7 mm3 in the control group and 1075.9±66.3 mm3 in the Simvastatin group), the density of bone in the lumbar spine or that in the formed fusion mass. Conclusions: Systemic use of Simvastatin caused a reduction in lipid biochemical parameters in treated animals. Successful spinal fusion as judged by manual palpation testing and fine detail radiography was not significantly different in treated versus untreated animals. The bone volume density of the formed fusion mass was not significantly different in treated versus untreated animals. There did not appear to be a significant advantage or disadvantage to the use of Simvastatin rabbit posterolateral spinal fusion. The potential positive effects of statins on bone require further study.

AB - Background context: There has been recent enthusiasm regarding the potential positive effects of statins on bone. Statins vary in their ability to influence bone activity. Simvastatin has been shown in experimental models to stimulate bone acting growth factors and enhance bone formation. Purpose: The potential efficacy of Simvastatin in enhancing spinal fusion was evaluated in a rabbit posterolateral intertransverse process fusion model. Study design/setting: Posterior lumbar intertransverse process spinal fusion performed on New Zealand White rabbits. Patient/study sample: 44 New Zealand White rabbits. Outcome measures: Spinal fusion as determined by manual palpation testing and fine detail radiography. Bone fusion mass volume and density as determined by CT scan imaging. Methods: Forty-four New Zealand White rabbits underwent posterolateral intertransverse process spine fusion using autogenous iliac crest bone graft. Simvastatin was administered orally in 20 animals and the serum lipid profile quantified in test and control animals. The animals were euthanized 9 weeks following index surgery and the lumbar spine was harvested. Spinal fusion was determined by manual palpation testing and fine detail radiography. The volume and density of the bone fusion mass was quantified by computed tomography. Results: Drug treatment for 9 weeks caused a reduction in serum lipid biochemical markers when compared with controls. The spinal fusion rate, as judged by manual palpation testing (13.0% control group, 16.6% Simvastatin group) and fine detail radiography, was not significantly different comparing treatment with control animals. Accordant with the assessment of spinal fusion, there was no statistically significant effect on the volume of the fusion mass (1224.7±98.7 mm3 in the control group and 1075.9±66.3 mm3 in the Simvastatin group), the density of bone in the lumbar spine or that in the formed fusion mass. Conclusions: Systemic use of Simvastatin caused a reduction in lipid biochemical parameters in treated animals. Successful spinal fusion as judged by manual palpation testing and fine detail radiography was not significantly different in treated versus untreated animals. The bone volume density of the formed fusion mass was not significantly different in treated versus untreated animals. There did not appear to be a significant advantage or disadvantage to the use of Simvastatin rabbit posterolateral spinal fusion. The potential positive effects of statins on bone require further study.

KW - Bone healing

KW - Spine

KW - Spine fusion

UR - http://www.scopus.com/inward/record.url?scp=33745551097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745551097&partnerID=8YFLogxK

U2 - 10.1016/j.spinee.2005.10.017

DO - 10.1016/j.spinee.2005.10.017

M3 - Article

VL - 6

SP - 391

EP - 396

JO - Spine Journal

JF - Spine Journal

SN - 1529-9430

IS - 4

ER -